Chancellor Merz Admits A "Considerable Proportion" Of Violence In Germany Comes "From Immigrant Groups"

Is The Iran War Good For The Petrodollar? Diana Choyleva wrote an excellent editorial for the Wall Street Journal entitled “The Iran War Is A Boon For The Petrodollar.” She pushes back against claims that the Iran conflict is accelerating the death of the petrodollar. Instead, RealInvestmentAdvice.com points out that she argues the opposite: between Iran and Venezuela, the U.S. is defending and bolstering dollar dominance in the oil trade. The 75-year-old petrodollar system rests on oil being priced and traded in dollars, which keeps the dollar prominent in all global trade. China has...

European Nationalists Rally Around Orbán Following Zelensky's "Outrageous" Remarks Authored by Thomas Brooke via Remix News, Hungarian Foreign Minister Péter Szijjártó has condemned remarks by Ukrainian President Volodymyr Zelensky that Budapest says amounted to a threat against Prime Minister Viktor Orbán. Responding to comments made during a press briefing in Kyiv on Thursday, Szijjártó said the statement was “beyond every limit” and reflected what he described as “the kind of ‘culture’ coming from Kyiv.” “This is the man Brussels admires and the country they want to fast-track into the European Union,” Szijjártó said....

Abivax Crashes Most On Record After Cancer Cases In Trial Data Spooks Wall Street French biotech Abivax suffered its largest intraday decline on record after reporting new data on its lead experimental inflammatory bowel disease drug, which showed cancer cases among patients in the clinical trial. The new data certainly point to regulatory headwinds and raise the risk profile for approval. Abivax's ABTECT maintenance data showed strong efficacy readout, with both once-daily obefazimod doses meeting the primary endpoint at week 44. Clinical remission rates were 50.8% for the 25 mg dose...